Submission Details
| 510(k) Number | K203066 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 09, 2020 |
| Decision Date | December 22, 2020 |
| Days to Decision | 74 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K203066 is an FDA 510(k) clearance for the COOLIEF Cooled Radiofrequency Kit Advanced, a Probe, Radiofrequency Lesion (Class II — Special Controls, product code GXI), submitted by Avanos Medical, Inc. (Alpharetta, US). The FDA issued a Cleared decision on December 22, 2020, 74 days after receiving the submission on October 9, 2020. This device falls under the Neurology review panel. Regulated under 21 CFR 882.4725.
| 510(k) Number | K203066 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 09, 2020 |
| Decision Date | December 22, 2020 |
| Days to Decision | 74 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GXI — Probe, Radiofrequency Lesion |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.4725 |